Article
Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs
4 May 2022
Abstract excerpt
Nonsense mutations or premature termination codons (PTCs) comprise ∼11% of all genetic lesions, which result in over 7,000 distinct genetic diseases. Due to their outsized impact on human health, considerable effort has been made to find therapies for nonsense-associated diseases. Suppressor tRNAs have long been identified as a possible therapeutic for nonsense-associated diseases; however, their ability to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
